With Tufts reporting that the average number of patient dropouts for clinical trials remains near 30%, it is clear that there is still much to be done towards improving retention¹.
One of the biggest drivers in keeping patients enrolled is the consent process. Traditional informed consent forms are frequently cited as confusing, leaving patients unsure of what their trial will require of them².
In order to improve the process, we must meet patients on their own terms and find new ways to educate and engage them. At Medable, we use our Patient Advisory Council (PAC) to review our own clinical trial technology and best practices, helping ensure patients leave the consent process truly informed.
Join Medable and key PAC members as we discuss common challenges faced by patients looking to participate in clinical trials. We will explore how a patient-first approach to informed consent can improve patient education, engagement, and comprehension, ultimately improving retention. Attendees will learn about:
1. The challenges of understanding consent information
2. Ideas on how to design the ICF and patient consent process to be patient-centric
3. Considerations in offering the choice of in-person or remote consent
4. Best practices in incorporating technology to increase engagement and comprehension
¹Applied Clinical Trials. Can Recruitment and Retention Get Any Worse? Dec 2019. Ken Getz
²Advarra. Retention in Clinical Trials: Keeping Patients on Protocols. Mar 2021.
Experienced drug development professional with a demonstrated history of working across multiple business areas within the research industry
Allison Kalloo, MPH is a patient recruitment specialist. She is the founding partner and communication lead of Clinical Ambassador, iParticipate and CliniVIVRE aimed at expanding minority access and broadening diversity in clinical research across stakeholders. She has held a variety of positions in the private, public, and non-profit sectors that span public relations, freelance writing, marketing, patient education and public health, and worked in multiple laboratories as an undergraduate research fellow.
Karen is the co-founder of the International Foundation for CDKL5 Research (IFCR), an organization that funds research and provides family..